![]() Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. | ![]() ARIAD Pharmaceuticals ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers. | ![]() Aura Biosciences Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology. | ||
Founding Date | Founding Date 2014 | Founding Date 2009 | Founding Date 1991 | Founding Date 2009 |
Type | Type Public | Type Public | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Sydney, AU HQ Kensington, AU Chuo City, JP Shinjuku City, JP Fort Lee, US | Locations Cambridge, US HQ Boston, US Chicago, US Cincinnati, US Dallas, US Minneapolis, US New York, US see more | Locations Cambridge, US HQ | |
Employees | Employees N/A | Employees 4843% increase | Employees 1381% increase | Employees 42 |
Valuation ($) | Valuation ($) 192.9 m | Valuation ($) 10.6 m | Valuation ($) N/A | Valuation ($) 544.2 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $638k (FY, 2025) | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) $118.8m (FY, 2015) | Revenue (est.) N/A |
Cost of goods | Cost of goods $159k (FY, 2025) | Cost of goods N/A | Cost of goods $2.1m (FY, 2015) | Cost of goods N/A |
Gross profit | Gross profit $562k (FY, 2025) | Gross profit N/A | Gross profit $116.7m (FY, 2015) | Gross profit N/A |
Net income | Net income ($4.5m) (FY, 2025) | Net income ($264.5m) (FY, 2021) | Net income ($231.2m) (FY, 2015) | Net income ($106.2m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 357m | Total funding raised N/A | Total funding raised $ 213.9m |

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
View company
ARIAD Pharmaceuticals is a global oncology company focused on discovering, developing and commercializing precision therapies for patients with rare cancers.
View company
Aura Biosciences is a clinical-stage biotechnology company that designs an oncology platform for the delivery of drugs targeting cancer indications, focusing on ocular and urologic oncology.
View company